Exclusive details on Silo Wellness' proposed acquisition of Dyscovry Science, a company that, unlike most of its peers in the psychedelics space, which focus on mental health issues, is targeting a physiological condition: irritable bowel syndrome.
Subscribe to:
Post Comments (Atom)
< + > Healthcare IT Failures – Healthcare IT Today Podcast Episode 195
For the 195th episode of the Healthcare IT Today Podcast , we are taking a look at healthcare IT failures! We kick this episode off by debat...
No comments:
Post a Comment